Worldwide Snakebites
(Year-To-Date)
Snakebites
Envenomations
Disabilities
Deaths

Selected Publications

We have included a small selection of peer-reviewed publications written by members of the Asclepius Snakebite Foundation below. Direct links to full text versions of the articles are included when they are available. 


Benjamin, J. M., Chippaux, J.-P., Sambo, B. T., & Massougbodji, A. (2018). Delayed double reading of whole blood clotting test (WBCT) results at 20 and 30 minutes enhances diagnosis and treatment of viper envenomation. Journal of Venomous Animals and Toxins Including Tropical Diseases, 24(1), 38. http://doi.org/10.1186/s40409-018-0151-1

Chippaux, J. P., Baldé, M. C., Sessinou, É., Yéro Boiro, M., & Massougbodji, A. (2015). [Evaluation of a new polyvalent antivenom against snakebite envenomation (Inoserp® Panafricain) in two different epidemiological settings: Northern Benin and Maritime Guinea]. Medecine Et Sante Tropicales, 25(1), 56–64. http://doi.org/10.1684/mst.2014.0413

Chippaux, J.-P. (2011). Estimate of the burden of snakebites in sub-Saharan Africa: A meta-analytic approach. Toxicon, 57(4), 586–599. http://doi.org/10.1016/j.toxicon.2010.12.022

Baldé, M. C., Chippaux, J.-P., Boiro, M. Y., Stock, R. P., & Massougbodji, A. (2013). Use of antivenoms for the treatment of envenomation by Elapidae snakes in Guinea, Sub-Saharan Africa. Journal of Venomous Animals and Toxins Including Tropical Diseases, 19(1), 6. http://doi.org/10.1186/1678-9199-19-6

Benjamin, J., & Gren, E. (2018). Neurotoxic snakebite in Guinea: Addressing a complex public health crisis. Toxicon, 150, 330. http://doi.org/10.1016/j.toxicon.2018.06.046

Chippaux, J.-P. (2017). Incidence and mortality due to snakebite in the Americas. PLoS Neglected Tropical Diseases, 11(6), e0005662–39. http://doi.org/10.1371/journal.pntd.0005662

Boyer, L. V., Seifert, S. A., Clark, R. F., McNally, J. T., Williams, S. R., Nordt, S. P., et al. (1999). Recurrent and persistent coagulopathy following pit viper envenomation. Archives of Internal Medicine, 159(7), 706–710.

Vonk, F. J., Jackson, K., Doley, R., Madaras, F., Mirtschin, P. J., & Vidal, N. (2011). Snake venom: From fieldwork to the clinic. BioEssays, 33(4), 269–279. http://doi.org/10.1002/bies.201000117

Vonk, F. J., Admiraal, J. F., Jackson, K., Reshef, R., de Bakker, M. A. G., Vanderschoot, K., et al. (2008). Evolutionary origin and development of snake fangs. Nature, 454(7204), 630–633. http://doi.org/10.1038/nature07178

Wüster, W., CHIRIO, L., TRAPE, J.-F., INEICH, I., Jackson, K., GREENBAUM, E., et al. (2018). Integration of nuclear and mitochondrial gene sequences and morphology reveals unexpected diversity in the forest cobra (Naja melanoleuca) species complex in Central and West Africa (Serpentes: Elapidae). Zootaxa, 4455(1), 68–32. http://doi.org/10.11646/zootaxa.4455.1.3

Habib, A. G., Kuznik, A., Hamza, M., Abdullahi, M. I., Chedi, B. A., Chippaux, J.-P., & Warrell, D. A. (2015). Snakebite is Under Appreciated: Appraisal of Burden from West Africa. PLoS Neglected Tropical Diseases, 9(9), e0004088–8. http://doi.org/10.1371/journal.pntd.0004088

Boyer, L. V., Theodorou, A. A., Berg, R. A., Mallie, J., Arizona Envenomation Investigators, Chávez-Méndez, A., et al. (2009). Antivenom for critically ill children with neurotoxicity from scorpion stings. The New England Journal of Medicine, 360(20), 2090–2098. http://doi.org/10.1056/NEJMoa0808455

Chippaux, J. (1998). Clinical safety of a polyvalent F(ab′)2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92(6), 657–662. http://doi.org/10.1016/s0035-9203(98)90802-1

Baldé, M. C., Chippaux, J. P., Boiro, M. Y., Stock, R., & Massougbodji, A. (2012). Clinical study of tolerance and effectiveness of a F(ab′)2 polyvalent antienom for African snake bites in Kindia, Guinea. Bulletin De La Société De Pathologie Exotique, 105(3), 157–161. http://doi.org/10.1007/s13149-012-0223-3

Dart, R. C., Seifert, S. A., Boyer, L. V., Clark, R. F., Hall, E., McKinney, P., et al. (2001). A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Archives of Internal Medicine, 161(16), 2030–2036.

Sunagar, K., Undheim, E. A. B., Scheib, H., Gren, E. C. K., Cochran, C., Person, C. E., et al. (2014). Intraspecific venom variation in the medically significant Southern Pacific Rattlesnake (Crotalus oreganus helleri): Biodiscovery, clinical and evolutionary implications. Journal of Proteomics, 99, 68–83. http://doi.org/10.1016/j.jprot.2014.01.013